A ranar 22 ga Mayu, 2025, Allist Pharmaceuticals ta sanar da cewa an amince da sabuwar maganinta mai suna Airuikai (Glecirasib Citrate Tablets), wani maganin hana KRAS-G12C, a hukumance don ƙaddamar da kasuwa ta Hukumar Kayayyakin Lafiya ta Ƙasa (NMPA). Amincewar ta ba da damar amfani da Airuikai don maganin manya marasa lafiya da ke fama da cutar kansar huhu ta KRAS®®G12C (NSCLC) wacce a baya ta sami aƙalla layi ɗaya na maganin. Wannan yana nuna wani sabon maganin cutar kansar huhu da aka amince da shi ga Allist Pharmaceuticals, yana ba da sabon zaɓi na magani ga marasa lafiya da ke fama da cutar kansar huhu ta KRASG12C (NSCLC) wacce aka canza ta KRASG12C kuma tana taimakawa wajen sake fasalin yanayin maganin wannan nau'in cutar kansa mai wahalar magani.
Amincewar ta dogara ne akan sakamakon wani muhimmin bincike na hannu ɗaya na Mataki na II wanda ke kimanta aminci, juriya, da ingancin maganin Glecirasib a cikin marasa lafiya da ke fama da cutar kansar huhu mai saurin kamuwa da ƙwayoyin cuta waɗanda ke ɗauke da KRASG12Cmutations waɗanda ko dai sun gaza ko kuma ba su jure wa jiyya ta yau da kullun ba.
Sakamakon ya nuna cewa Goleresai yana da tasiri kuma yana da haƙuri sosai. Ya zuwa ranar 28 ga Satumba, 2024, an haɗa jimillar marasa lafiya 119 na NSCLC a cikin binciken. An tabbatar da ƙimar amsawar da aka samu ta hanyar amfani da hankali (cORR), kamar yadda Kwamitin Bita Mai Zaman Kansa (IRC) ya kimanta, shine 49.6% (40.2%-59.0%), tare da ƙimar kula da cututtuka (DCR) na 86.3% (78.7%-92.0%). Matsakaicin tsawon lokacin amsawa (DOR) shine watanni 14.5 (watanni 9.6 zuwa ba za a iya kimantawa ba), matsakaicin rayuwa ba tare da ci gaba ba (PFS) shine watanni 8.2 (5.2–11.1), kuma matsakaicin rayuwa gabaɗaya (OS) shine watanni 17.5 (watanni 13.6 zuwa ba za a iya kimantawa ba).
A halin yanzu, har yanzu akwai gwaje-gwaje da yawa na asibiti na sabbin fasahohin yaƙi da cutar kansa a China waɗanda ke neman marasa lafiya. Tuntuɓi kan sabbin magunguna da fasahohi, zaku iya tuntuɓar Sashen Ƙasa da Ƙasa na Asibitin Oncology na Yankin Kudu na Beijing.
Lambar Waya: 4008803716
Email：myimmnet@163.com
Lokacin Saƙo: Mayu-27-2025